{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T05:44:28Z","timestamp":1792215868652,"version":"4.4.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012051","name":"Lupus Research Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018353","name":"European Crohn's & Colitis Organisation","doi-asserted-by":"publisher","award":["ECCO Grant"],"award-info":[{"award-number":["ECCO Grant"]}],"id":[{"id":"10.13039\/100018353","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005032","name":"Funda\u00e7\u00e3o Bial","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005032","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["CEECINSTLA\/00017\/2022\/CP3016\/CT0004"],"award-info":[{"award-number":["CEECINSTLA\/00017\/2022\/CP3016\/CT0004"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["2024.16477.PEX"],"award-info":[{"award-number":["2024.16477.PEX"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["2022.01422.PTDC"],"award-info":[{"award-number":["2022.01422.PTDC"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["2025.02359.BD"],"award-info":[{"award-number":["2025.02359.BD"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["2022.00337.CEECIND"],"award-info":[{"award-number":["2022.00337.CEECIND"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["2023.16654.ICDT"],"award-info":[{"award-number":["2023.16654.ICDT"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["2024.16867.PEX"],"award-info":[{"award-number":["2024.16867.PEX"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["2023.15441.TENURE.011"],"award-info":[{"award-number":["2023.15441.TENURE.011"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["2020.00088.CEECIND\/CP1608\/CT0001"],"award-info":[{"award-number":["2020.00088.CEECIND\/CP1608\/CT0001"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["2024.15597.PEX"],"award-info":[{"award-number":["2024.15597.PEX"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013175","name":"European Society for Clinical Investigation","doi-asserted-by":"publisher","award":["ESCI Exploratory Research Grant 2024"],"award-info":[{"award-number":["ESCI Exploratory Research Grant 2024"]}],"id":[{"id":"10.13039\/501100013175","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["GlycanSwitch"],"award-info":[{"award-number":["GlycanSwitch"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["101071386"],"award-info":[{"award-number":["101071386"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003042","name":"Else Kroner-Fresenius Foundation","doi-asserted-by":"publisher","award":["2022_EKMK.13"],"award-info":[{"award-number":["2022_EKMK.13"]}],"id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jaut.2026.103643","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T04:58:40Z","timestamp":1792126720000},"page":"103643","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Treg-associated oligomannose N-glycans trigger immune dysregulation in myasthenia gravis"],"prefix":"10.1016","volume":"165","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7375-387X","authenticated-orcid":false,"given":"Pedro","family":"Carneiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2961-0801","authenticated-orcid":false,"given":"Manuel M.","family":"Vicente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3914-7101","authenticated-orcid":false,"given":"In\u00eas","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catarina M.","family":"Azevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00cdris","family":"Caramalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Gaifem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Tente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Isabel","family":"Leite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernestina","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salom\u00e9 S.","family":"Pinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c2ngela","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.jaut.2026.103643_bib1","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nri916","article-title":"Unravelling the pathogenesis of myasthenia gravis","volume":"2","author":"Vincent","year":"2002","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.jaut.2026.103643_bib2","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1471-2377-10-46","article-title":"A systematic review of population based epidemiological studies in Myasthenia Gravis","volume":"10","author":"Carr","year":"2010","journal-title":"BMC Neurol."},{"issue":"2","key":"10.1016\/j.jaut.2026.103643_bib3","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ncl.2018.01.002","article-title":"Generalized myasthenia gravis: classification, clinical presentation, natural history, and epidemiology","volume":"36","author":"Hehir","year":"2018","journal-title":"Neurol. Clin."},{"issue":"3","key":"10.1016\/j.jaut.2026.103643_bib4","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/cei.12217","article-title":"Myasthenia gravis: an update for the clinician","volume":"175","author":"Sieb","year":"2014","journal-title":"Clin. Exp. Immunol."},{"issue":"3","key":"10.1016\/j.jaut.2026.103643_bib5","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/mus.25068","article-title":"Epidemiology of myasthenia gravis in Northern Portugal: frequency estimates and clinical epidemiological distribution of cases","volume":"54","author":"Santos","year":"2016","journal-title":"Muscle Nerve"},{"issue":"10","key":"10.1016\/j.jaut.2026.103643_bib6","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","article-title":"Myasthenia gravis: subgroup classification and therapeutic strategies","volume":"14","author":"Gilhus","year":"2015","journal-title":"Lancet Neurol."},{"issue":"Jan","key":"10.1016\/j.jaut.2026.103643_bib7","article-title":"When myasthenia gravis is deemed refractory: clinical signposts and treatment strategies","volume":"11","author":"Mantegazza","year":"2018","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"5","key":"10.1016\/j.jaut.2026.103643_bib8","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s40259-020-00443-w","article-title":"Monoclonal antibody-based therapies for Myasthenia gravis","volume":"34","author":"Alabbad","year":"2020","journal-title":"BioDrugs"},{"issue":"7","key":"10.1016\/j.jaut.2026.103643_bib9","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41577-024-00994-x","article-title":"The regulation and differentiation of regulatory T cells and their dysfunction in autoimmune diseases","volume":"24","author":"Sumida","year":"2024","journal-title":"Nat. Rev. Immunol."},{"issue":"23","key":"10.1016\/j.jaut.2026.103643_bib10","doi-asserted-by":"crossref","DOI":"10.1172\/JCI202216","article-title":"The 2025 Nobel Prize in Physiology or Medicine \u2014 a bridge to peripheral immune tolerance","volume":"135","author":"Bluestone","year":"2025","journal-title":"J. Clin. Investig."},{"issue":"2","key":"10.1016\/j.jaut.2026.103643_bib11","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.immuni.2023.01.004","article-title":"Principles of regulatory T cell function","volume":"56","author":"Dikiy","year":"2023","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.jaut.2026.103643_bib12","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.clim.2012.09.012","article-title":"Impaired regulatory function in circulating CD4+CD25highCD127low\/\u2212 T cells in patients with myasthenia gravis","volume":"145","author":"Thiruppathi","year":"2012","journal-title":"Clin. Immunol."},{"issue":"1","key":"10.1016\/j.jaut.2026.103643_bib13","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1749-6632.2012.06840.x","article-title":"Functional defect in regulatory T cells in myasthenia gravis","volume":"1274","author":"Thiruppathi","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"3","key":"10.1016\/j.jaut.2026.103643_bib14","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1084\/jem.20040165","article-title":"Compromised function of regulatory T cells in Rheumatoid arthritis and reversal by Anti-TNF\u03b1 therapy","volume":"200","author":"Ehrenstein","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2026.103643_bib15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jaut.2013.12.015","article-title":"Both Treg cells and Tconv cells are defective in the Myasthenia gravis thymus: roles of IL-17 and TNF-\u03b1","volume":"52","author":"Gradolatto","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2026.103643_bib16","series-title":"Inflammation and Autoimmune Myasthenia Gravis","author":"Huda","year":"2023"},{"key":"10.1016\/j.jaut.2026.103643_bib17","article-title":"Myasthenia Gravis treatment: from old drugs to innovative therapies with a glimpse into the future","author":"Crisafulli","year":"2024","journal-title":"Adis"},{"issue":"8","key":"10.1016\/j.jaut.2026.103643_bib18","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.4049\/jimmunol.2100225","article-title":"Elevated N-Linked glycosylation of IgG V regions in Myasthenia Gravis disease subtypes","volume":"207","author":"Mandel-Brehm","year":"2021","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2026.103643_bib19","series-title":"Essentials of Glycobiology","author":"Varki","year":"2022"},{"key":"10.1016\/j.jaut.2026.103643_bib20","series-title":"Glycans as Key Checkpoints of T Cell Activity and Function","author":"Pereira","year":"2018"},{"issue":"10","key":"10.1016\/j.jaut.2026.103643_bib21","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1158\/2326-6066.CIR-25-0313","article-title":"Reprogramming CD8+ T-cell branched N- glycosylation limits exhaustion, enhancing cytotoxicity and tumor killing","volume":"13","author":"Azevedo","year":"2025","journal-title":"Cancer Immunol. Res."},{"issue":"11","key":"10.1016\/j.jaut.2026.103643_bib22","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1158\/2326-6066.CIR-20-0264","article-title":"Glycans as immune checkpoints: removal of branched N-glycans enhances immune recognition preventing cancer progression","volume":"8","author":"Silva","year":"2020","journal-title":"Cancer Immunol. Res."},{"issue":"8","key":"10.1016\/j.jaut.2026.103643_bib23","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.it.2023.06.004","article-title":"Glycome dynamics in T and B cell development: basic immunological mechanisms and clinical applications","volume":"44","author":"Vicente","year":"2023","journal-title":"Trends Immunol."},{"issue":"10","key":"10.1016\/j.jaut.2026.103643_bib24","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/s41423-023-01074-1","article-title":"Immune regulatory networks coordinated by glycans and glycan-binding proteins in autoimmunity and infection","volume":"20","author":"Pinho","year":"2023","journal-title":"Cell. Mol. Immunol."},{"issue":"8","key":"10.1016\/j.jaut.2026.103643_bib25","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/s41423-023-01052-7","article-title":"Mannosylated glycans impair normal T-cell development by reprogramming commitment and repertoire diversity","volume":"20","author":"Vicente","year":"2023","journal-title":"Cell. Mol. Immunol."},{"issue":"Aug","key":"10.1016\/j.jaut.2026.103643_bib26","article-title":"Distinctive surface glycosylation patterns associated with mouse and Human CD4+ regulatory T cells and their suppressive function","volume":"8","author":"Cabral","year":"2017","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.jaut.2026.103643_bib27","article-title":"Experimental Autoimmune Myasthenia Gravis in the mouse","volume":"100","author":"Wu","year":"2013","journal-title":"Curr. Protoc. Im."},{"issue":"5","key":"10.1016\/j.jaut.2026.103643_bib28","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1080\/08820139.2017.1299754","article-title":"Immunization with recombinantly expressed LRP4 induces Experimental Autoimmune Myasthenia Gravis in C57BL\/6 mice","volume":"46","author":"Ulusoy","year":"2017","journal-title":"Immunol. Investig."},{"issue":"2","key":"10.1016\/j.jaut.2026.103643_bib29","article-title":"Single-cell transcriptome landscape of circulating CD4+ T cell populations in autoimmune diseases","volume":"4","author":"Yasumizu","year":"2024","journal-title":"Cell Genom."},{"issue":"1","key":"10.1016\/j.jaut.2026.103643_bib30","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13059-017-1382-0","article-title":"SCANPY: large-scale single-cell gene expression data analysis","volume":"19","author":"Wolf","year":"2018","journal-title":"Genome Biol."},{"key":"10.1016\/j.jaut.2026.103643_bib31","article-title":"Regulatory T cells in multiple sclerosis and myasthenia gravis","author":"Danikowski","year":"2017","journal-title":"BioMed Central Ltd"},{"key":"10.1016\/j.jaut.2026.103643_bib32","series-title":"Current Treatment, Emerging Translational Therapies, and New Therapeutic Targets for Autoimmune Myasthenia Gravis","author":"Guptill","year":"2016"},{"issue":"6","key":"10.1016\/j.jaut.2026.103643_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2025.103791","article-title":"The role of N-glycans in regulatory T cells in autoimmunity","volume":"24","author":"Carneiro","year":"2025","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.jaut.2026.103643_bib34","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/ncomms1333","article-title":"Genetics and the environment converge to dysregulate N-glycosylation in multiple sclerosis","volume":"2","author":"Mkhikian","year":"2011","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.jaut.2026.103643_bib35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jhep.2004.03.008","article-title":"Impairment of CD4+CD25+ regulatory T-cells in autoimmune liver disease","volume":"41","author":"Longhi","year":"2004","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.jaut.2026.103643_bib36","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/art.23268","article-title":"Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-\u03b1-producing antigen-presenting cells","volume":"58","author":"Yan","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"9","key":"10.1016\/j.jaut.2026.103643_bib37","doi-asserted-by":"crossref","first-page":"6411","DOI":"10.4049\/jimmunol.180.9.6411","article-title":"Natural naive CD4+CD25+CD127low regulatory T cell (Treg) development and function are disturbed in multiple sclerosis patients: recovery of memory treg homeostasis during disease progression","volume":"180","author":"Venken","year":"2008","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.jaut.2026.103643_bib38","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.4049\/jimmunol.179.2.1322","article-title":"Prevalence of newly generated naive regulatory T cells (Treg) is critical for treg suppressive function and determines treg dysfunction in multiple sclerosis","volume":"179","author":"Haas","year":"2007","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.jaut.2026.103643_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/cells10040801","article-title":"Peripheral blood from rheumatoid arthritis patients shows decreased treg cd25 expression and reduced frequency of effector treg subpopulation","volume":"10","author":"Go","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jaut.2026.103643_bib40","series-title":"Mechanisms of Impaired Regulation by CD4+ CD25+ FOXP3+ Regulatory T Cells in Human Autoimmune Diseases","author":"Buckner","year":"2010"},{"issue":"2","key":"10.1016\/j.jaut.2026.103643_bib41","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/cei.12116","article-title":"CD4+CD45RA-FoxP3high activated regulatory T cells are functionally impaired and related to residual insulin-secreting capacity in patients with type 1 diabetes","volume":"173","author":"Haseda","year":"2013","journal-title":"Clin. Exp. Immunol."},{"issue":"12","key":"10.1016\/j.jaut.2026.103643_bib42","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1097\/MIB.0b013e3182a85709","article-title":"Increased prevalence of circulating novel IL-17 secreting Foxp3 expressing CD4+ T cells and defective suppressive function of circulating Foxp3+ regulatory cells support plasticity between Th17 and regulatory T cells in inflammatory bowel disease patients","volume":"19","author":"Ueno","year":"2013","journal-title":"Inflamm. Bowel Dis."},{"issue":"49","key":"10.1016\/j.jaut.2026.103643_bib43","doi-asserted-by":"crossref","first-page":"19396","DOI":"10.1073\/pnas.0806855105","article-title":"Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis","volume":"105","author":"Flores-Borja","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jaut.2026.103643_bib44","article-title":"Low frequency of CD4+CD25+ Treg in SLE patients: a heritable trait associated with CTLA4 and TGF\u03b2 gene variants","volume":"10","author":"Barreto","year":"2007","journal-title":"BMC Immunol."},{"issue":"8","key":"10.1016\/j.jaut.2026.103643_bib45","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.388","article-title":"Increased tumor-infiltrating CD45RA\u2212CCR7\u2212 regulatory T-cell subset with immunosuppressive properties foster gastric cancer progress","volume":"8","author":"Mao","year":"2017","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.jaut.2026.103643_bib46","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.celrep.2017.09.016","article-title":"CCR7 modulates the generation of thymic regulatory T cells by altering the composition of the thymic dendritic cell compartment","volume":"21","author":"Hu","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.jaut.2026.103643_bib47","first-page":"1","article-title":"Defects of CTLA-4 are associated with regulatory T cells in Myasthenia gravis implicated by intravenous immunoglobulin therapy","volume":"2020","author":"Xu","year":"2020","journal-title":"Mediat. Inflamm."},{"issue":"1","key":"10.1016\/j.jaut.2026.103643_bib48","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.imlet.2008.11.015","article-title":"The role of FoxP3+CD4+CD25hi tregs in the pathogenesis of myasthenia gravis","volume":"122","author":"Zhang","year":"2009","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.jaut.2026.103643_bib49","series-title":"Functional Defect of Regulatory CD4 CD25 T Cells in the Thymus of Patients with Autoimmune Myasthenia Gravis","author":"Balandina","year":"2005"},{"key":"10.1016\/j.jaut.2026.103643_bib50","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.14814","article-title":"Golgi self-correction generates bioequivalent glycans to preserve cellular homeostasis","volume":"5","author":"Mkhikian","year":"2016","journal-title":"eLife"},{"issue":"15","key":"10.1016\/j.jaut.2026.103643_bib51","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.3390\/cells13151282","article-title":"Cell-Based therapy and genome editing as emerging therapeutic approaches to treat rheumatoid arthritis","volume":"13","author":"Chasov","year":"2024","journal-title":"Cells"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841126001216?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841126001216?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T05:23:04Z","timestamp":1792214584000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841126001216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":51,"alternative-id":["S0896841126001216"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2026.103643","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treg-associated oligomannose N-glycans trigger immune dysregulation in myasthenia gravis","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2026.103643","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103643"}}